Partial splenic embolization with Glubran2/Lipiodol mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy.

Fiche publication

Date publication

mars 2019

Journal

Quantitative imaging in medicine and surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François , Dr VINCENT Julie , Pr LOFFROY Romaric

Tous les auteurs :
Loffroy R, Falvo N, Nakaï M, Pescatori L, Aho-Gléglé S, Gehin S, Berthod PE, Né R, Vincent J, Ghiringhelli F, Midulla M, Chevallier O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31032188

Résumé

Partial splenic embolization (PSE) has been used to improve thrombocytopenia related to hypersplenism. The optimal embolic agent is still debated. The purpose of this study was to evaluate the safety, hematologic response and outcomes of PSE with cyanoacrylate glue for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapy (SC).